These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

171 related articles for article (PubMed ID: 19578473)

  • 1. Expanding the Concepts in Protein Structure-Function Relationships and Enzyme Kinetics: Teaching using Morpheeins.
    Lawrence SH; Jaffe EK
    Biochem Mol Biol Educ; 2008; 36(4):274-283. PubMed ID: 19578473
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Single amino acid mutations alter the distribution of human porphobilinogen synthase quaternary structure isoforms (morpheeins).
    Tang L; Breinig S; Stith L; Mischel A; Tannir J; Kokona B; Fairman R; Jaffe EK
    J Biol Chem; 2006 Mar; 281(10):6682-90. PubMed ID: 16377642
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Morpheeins--a new structural paradigm for allosteric regulation.
    Jaffe EK
    Trends Biochem Sci; 2005 Sep; 30(9):490-7. PubMed ID: 16023348
    [TBL] [Abstract][Full Text] [Related]  

  • 4. MORPHEEINS - A NEW PATHWAY FOR ALLOSTERIC DRUG DISCOVERY.
    Jaffe EK
    Open Conf Proc J; 2010; 1():1-6. PubMed ID: 21643557
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Kinetics and thermodynamics of the interchange of the morpheein forms of human porphobilinogen synthase.
    Selwood T; Tang L; Lawrence SH; Anokhina Y; Jaffe EK
    Biochemistry; 2008 Mar; 47(10):3245-57. PubMed ID: 18271513
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Porphobilinogen synthase: An equilibrium of different assemblies in human health.
    Jaffe EK
    Prog Mol Biol Transl Sci; 2020; 169():85-104. PubMed ID: 31952692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The morpheein model of allostery: evaluating proteins as potential morpheeins.
    Jaffe EK; Lawrence SH
    Methods Mol Biol; 2012; 796():217-31. PubMed ID: 22052493
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dynamic dissociating homo-oligomers and the control of protein function.
    Selwood T; Jaffe EK
    Arch Biochem Biophys; 2012 Mar; 519(2):131-43. PubMed ID: 22182754
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ALAD porphyria is a conformational disease.
    Jaffe EK; Stith L
    Am J Hum Genet; 2007 Feb; 80(2):329-37. PubMed ID: 17236137
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Docking to large allosteric binding sites on protein surfaces.
    Ramirez UD; Myachina F; Stith L; Jaffe EK
    Adv Exp Med Biol; 2010; 680():481-8. PubMed ID: 20865533
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Remarkable Character of Porphobilinogen Synthase.
    Jaffe EK
    Acc Chem Res; 2016 Nov; 49(11):2509-2517. PubMed ID: 27783504
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Shape shifting leads to small-molecule allosteric drug discovery.
    Lawrence SH; Ramirez UD; Tang L; Fazliyez F; Kundrat L; Markham GD; Jaffe EK
    Chem Biol; 2008 Jun; 15(6):586-96. PubMed ID: 18559269
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impact of quaternary structure dynamics on allosteric drug discovery.
    Jaffe EK
    Curr Top Med Chem; 2013; 13(1):55-63. PubMed ID: 23409765
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Control of tetrapyrrole biosynthesis by alternate quaternary forms of porphobilinogen synthase.
    Breinig S; Kervinen J; Stith L; Wasson AS; Fairman R; Wlodawer A; Zdanov A; Jaffe EK
    Nat Struct Biol; 2003 Sep; 10(9):757-63. PubMed ID: 12897770
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Taking Advantage of the Morpheein Behavior of Peroxiredoxin in Bionanotechnology.
    Ardini M; Bellelli A; Williams DL; Di Leandro L; Giansanti F; Cimini A; Ippoliti R; Angelucci F
    Bioconjug Chem; 2021 Jan; 32(1):43-62. PubMed ID: 33411522
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Wrangling Shape-Shifting Morpheeins to Tackle Disease and Approach Drug Discovery.
    Jaffe EK
    Front Mol Biosci; 2020; 7():582966. PubMed ID: 33330623
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Probing the oligomeric assemblies of pea porphobilinogen synthase by analytical ultracentrifugation.
    Kokona B; Rigotti DJ; Wasson AS; Lawrence SH; Jaffe EK; Fairman R
    Biochemistry; 2008 Oct; 47(40):10649-56. PubMed ID: 18795796
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Environmental contaminants perturb fragile protein assemblies and inhibit normal protein function.
    Lawrence SH; Selwood T; Jaffe EK
    Curr Chem Biol; 2013; 7(2):196-206. PubMed ID: 25045409
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Substrate-induced interconversion of protein quaternary structure isoforms.
    Tang L; Stith L; Jaffe EK
    J Biol Chem; 2005 Apr; 280(16):15786-93. PubMed ID: 15710608
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Structural basis for morpheein-type allosteric regulation of Escherichia coli glucosamine-6-phosphate synthase: equilibrium between inactive hexamer and active dimer.
    Mouilleron S; Badet-Denisot MA; Pecqueur L; Madiona K; Assrir N; Badet B; Golinelli-Pimpaneau B
    J Biol Chem; 2012 Oct; 287(41):34533-46. PubMed ID: 22851174
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.